Wells Fargo & Company Issues Positive Forecast for Liquidia (NASDAQ:LQDA) Stock Price

Liquidia (NASDAQ:LQDA) had its target price boosted by Wells Fargo & Company from $44.00 to $51.00 in a report published on Monday morning,Benzinga reports. They currently have an overweight rating on the stock.

LQDA has been the topic of several other research reports. Wall Street Zen upgraded shares of Liquidia from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. BTIG Research raised their price objective on shares of Liquidia from $49.00 to $50.00 and gave the company a “buy” rating in a research report on Thursday, March 5th. Lifesci Capital raised shares of Liquidia to a “strong-buy” rating in a research note on Thursday, March 5th. Needham & Company LLC upped their target price on shares of Liquidia from $52.00 to $54.00 and gave the stock a “buy” rating in a research report on Thursday, March 5th. Finally, HC Wainwright increased their price target on shares of Liquidia from $50.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Liquidia currently has an average rating of “Moderate Buy” and an average target price of $43.44.

Liquidia Stock Down 2.5%

Shares of LQDA opened at $35.50 on Monday. The company has a market capitalization of $3.13 billion, a P/E ratio of -42.77 and a beta of 0.52. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.01 and a quick ratio of 1.84. Liquidia has a one year low of $11.26 and a one year high of $46.67. The business’s 50 day simple moving average is $37.87 and its 200-day simple moving average is $31.65.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.07. The firm had revenue of $92.02 million during the quarter, compared to analysts’ expectations of $87.49 million. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.Liquidia’s quarterly revenue was up 3072.4% compared to the same quarter last year. As a group, sell-side analysts predict that Liquidia will post -1.51 EPS for the current fiscal year.

Insider Transactions at Liquidia

In other Liquidia news, General Counsel Russell Schundler sold 27,289 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $37.43, for a total transaction of $1,021,427.27. Following the transaction, the general counsel directly owned 579,394 shares in the company, valued at approximately $21,686,717.42. This represents a 4.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Rajeev Saggar sold 21,142 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $37.43, for a total transaction of $791,345.06. Following the sale, the insider directly owned 176,883 shares of the company’s stock, valued at approximately $6,620,730.69. This trade represents a 10.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 212,534 shares of company stock valued at $7,964,719. 26.50% of the stock is currently owned by insiders.

Institutional Trading of Liquidia

Several institutional investors and hedge funds have recently made changes to their positions in the business. Federated Hermes Inc. acquired a new stake in shares of Liquidia during the third quarter worth $7,290,000. Caprock Group LLC acquired a new position in Liquidia in the third quarter valued at about $37,114,000. Apis Capital Advisors LLC acquired a new position in Liquidia in the third quarter valued at about $9,569,000. Farallon Capital Management LLC boosted its holdings in Liquidia by 102.1% during the third quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock worth $194,783,000 after buying an additional 4,326,876 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new position in Liquidia during the third quarter worth about $2,026,000. Institutional investors own 64.54% of the company’s stock.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).